APOE and hyperlipidemia: Although we have successfully generated LDLR and LDLR/apoE double KO rabbit model with the spontaneous hyperlipidemia, but their genetic mutations are different from patients and also their plasma lipids are significantly higher than patients, which may limit their subsequent clinical translational applications.